Cargando…

The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus

OBJECTIVE: Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán Gómez, Guillermo E., Viggiano, Julian A., Silva-De Las Salas, A., Martínez, Veline, Urbano Bonilla, María A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478568/
https://www.ncbi.nlm.nih.gov/pubmed/34594581
http://dx.doi.org/10.1155/2021/7310176
Descripción
Sumario:OBJECTIVE: Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Design and Methods. We reviewed the case of a G1P0 patient with type 1 diabetes, treated with the Medtronic 670G system during pregnancy; a comparison with current literature was done. RESULTS: The patient achieved improved glycemic control as measured by time spent in different ranges as follows: <70 mg/dL, 8–4% and 70–180 mg/dL, 83–94%. Secondary outcomes included reduction of stress, anxiety, fear of hypoglycemia, and the psychological burden related to the disease. There were no obstetric or neonatal complications. CONCLUSION: The Medtronic 670G closed-loop system was used safely in a pregnant woman; nevertheless, further research is needed to validate this system in this patient population.